-
-
-
-
-
-
-
Compugen (CGEN) Misses Q2 EPS by 2c
-
-
-
-
-
-
-
Compugen Reports Fourth Quarter and Full Year 2024 Results
-
-
-
-
-
-
-
Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024
-
-
-
-
-
-
-
Gilead Sciences (GILD) and Compugen (CGEN) Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program
-
-
-
-
-
-
-
Compugen to Release Second Quarter 2023 Results on Monday, August 7, 2023
-
-
-
-
-
-
-
Compugen (CGEN) Misses Q3 EPS by 2c
-
-
-
-
-
-
-
Compugen (CGEN) Issues Letter to Shareholders
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

